Skip to main content
Sign In

An official website of the United States government

U.S. Department of Health & Human Services

Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

​​Call for Public Comments: National Biodefense Strategy Implementation

Comment period closed on May 1, 2019.

​Nearly 800 people joined in a public conversation April 17, 2019 to discuss non-federal biodefense actions that have been taken or are needed to protect the American people from biological threats. Even if you missed the discussion, you can still submit your input as part of an information assessment that will be used to help drive the comprehensive coordination of federal biodefense actions and budgets, as called for in the National Biodefense Strategy. While interaction with non-federal organizations and agencies will continue, input received by May 1, 2019, will be considered in the federal assessment.

The National Biodefense Strategy sets the course for U.S. to combat the real and serious biothreats our country faces, whether they arise from natural outbreaks of disease, accidents involving high consequence pathogens, or the actions of terrorists or state actors.

Goal 1 – Enabling Risk Awareness to Inform Decision Making across the Biodefense Enterprise

      • What are the most significant gaps or challenges, either at the national level or within your business sector, related to the implementation of Goal 1 of the Strategy (Risk Awareness)?
      • What are the highest priority actions addressing Goal 1 of the Strategy that would best advance biodefense?
      • What new initiatives are planned by your sector that would contribute to filling gaps in risk awareness and informed decision making as it applies to national biodefense?
      • What proposed initiatives would be most effective in enhancing risk awareness and informed biodefense-related decision making by leaders?

Goal 2 – Ensure Biodefense Enterprise Capabilities to Prevent Bioincidents

      • What are the most significant gaps or challenges, either at the national level or within your business sector, related to implementation of Goal 2 of the Strategy (Prevention)?
      • What are the highest priority actions addressing Goal 2 of the Strategy that would best advance biodefense?
      • What new initiatives are planned by your sector that would contribute to filling gaps in preventing bioincidents?
      • What proposed initiatives would be most effective in preventing bioincidents?

Goal 3 – Ensure Biodefense Preparedness Enterprise to Reduce the Impacts of Bioincidents

      • What are the most significant gaps or challenges, either at the national level or within your business sector, related to implementation of Goal 3 of the Strategy (Preparedness)?
      • What are the highest priority actions addressing Goal 3 of the Strategy that would best advance biodefense?
      • What new initiatives are planned by your sector that would contribute to filling gaps in preparing for bioincidents?
      • What proposed initiatives would be most effective in biodefense enterprise preparedness to reduce the impacts of bioincidents?

Goal 4 – Rapidly Respond to Limit the Impacts of Bioincidents

      • What are the most significant gaps or challenges, either at the national level or within your business sector, related to implementation of Goal 4 of the Strategy (Response)?
      • What are the highest priority actions addressing Goal 4 of the Strategy that would best advance biodefense?
      • What new initiatives planned by your sector that would contribute to filling gaps in our ability to rapidly respond to limit the impacts of bioincidents?
      • What proposed initiatives would be most effective in ensuring fast and effective bioincident response capabilities in the United States?

Goal 5 – Facilitate Recovery to Restore the Community, the Economy, and the Environment after a Bioincident?

      • What are the most significant gaps or challenges, either at the national level or within your business sector, related to implementation of Goal 5 of the Strategy (Recovery)?
      • What are the highest priority actions addressing Goal 5 of the Strategy that would best advance biodefense?
      • What new initiatives are planned by your sector that would contribute to filling gaps in our ability to recover and restore the community, the economy, and the environment after a bioincident?
      • What proposed initiatives would be most effective in ensuring a robust national capacity to recover from bioincidents?

Cross-cutting Themes

      • How can the Federal Government best engage and coordinate with non-Federal stakeholders to fulfill the goals of the Strategy?
      • Are there any new or innovative approaches for either the Federal Government or Stakeholders to take in order to better implement the goals of the Strategy?

Written information that is submitted may be made be available to the public; therefore, we request that statements do not include private or proprietary information. Please submit your written comments to ASPRBIO@hhs.gov no later than May 1, 2019.​​​​​​

Biodefense Right Nav

National Biodefense Strategy